|
|
||||||||
The Journal of Immunology, Vol 143, Issue 5 1619-1627, Copyright © 1989 by American Association of Immunologists
ARTICLES |
M Mawatari, K Kohno, H Mizoguchi, T Matsuda, K Asoh, J Van Damme, HG Welgus and M Kuwano
Department of Biochemistry, Oita Medical School, Japan.
The effect of human TNF on cultured human microvascular endothelial (HME) cells was examined. Incubation with TNF alone transformed the morphology of HME cells from a cobblestone-like appearance into a disordered array of criss-crossed, elongated, spindle-shaped cells. Coadministration of epidermal growth factor (EGF) and TNF caused even more dramatic morphologic changes than TNF alone. Addition of basic fibroblast growth factor or insulin-like growth factor-I showed rather weak effects on cell morphology than EGF. Cell growth of HME cells was stimulated up to two-fold by TNF whereas addition of EGF additively enhanced the growth rate. Treatment of HME cells with 10 ng/ml EGF increased the binding of 125I-TNF, and Scatchard analysis showed increased TNF-R number by EGF treatment. Cellular response to TNF in the absence or presence of EGF was assessed by analyzing SDS-PAGE patterns of secreted proteins from HME cells. TNF enhanced the secretion of a protein of molecular weight 25,000 Da (25 kDa) which was found to be IL-6. In contrast, secretion of a polypeptide of 29 kDa was significantly increased when HME cells were treated with EGF, but not with TNF. Coadministration of TNF and EGF synergistically increased the secretion of the 29-kDa protein. This 29-kDa protein was found to be tissue inhibitor of metalloproteinases when assayed with antitissue inhibitor of metalloproteinases antibody. TNF and EGF also enhanced secretion of collagenase with Mr of approximately 55 kDa. Increased steady state levels of the inhibitor mRNA were observed when HME cells were treated with EGF, and coadministration of TNF further increased the levels. The morphologic transformation of HME cells by TNF and/or EGF is discussed in relation to their expression of the secreted proteins.
This article has been cited by other articles:
![]() |
U. Stein, K. Jurchott, M. Schlafke, and P. Hohenberger Expression of Multidrug Resistance Genes MVP, MDR1, and MRP1 Determined Sequentially Before, During, and After Hyperthermic Isolated Limb Perfusion of Soft Tissue Sarcoma and Melanoma Patients J. Clin. Oncol., August 1, 2002; 20(15): 3282 - 3292. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hirata, S.-i. Ogawa, T. Kometani, T. Kuwano, S. Naito, M. Kuwano, and M. Ono ZD1839 (Iressa) Induces Antiangiogenic Effects through Inhibition of Epidermal Growth Factor Receptor Tyrosine Kinase Cancer Res., May 1, 2002; 62(9): 2554 - 2560. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-i. Fukushi, M. Ono, W. Morikawa, Y. Iwamoto, and M. Kuwano The Activity of Soluble VCAM-1 in Angiogenesis Stimulated by IL-4 and IL-13 J. Immunol., September 1, 2000; 165(5): 2818 - 2823. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Shiraha, A. Glading, K. Gupta, and A. Wells IP-10 Inhibits Epidermal Growth Factor–induced Motility by Decreasing Epidermal Growth Factor Receptor–mediated Calpain Activity J. Cell Biol., July 12, 1999; 146(1): 243 - 254. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lefer, P Tsao, N Aoki, and M. Palladino Jr Mediation of cardioprotection by transforming growth factor-beta Science, July 6, 1990; 249(4964): 61 - 64. [Abstract] [PDF] |
||||
![]() |
W. Morikawa, K. Yamamoto, S. Ishikawa, S. Takemoto, M. Ono, J.-i. Fukushi, S. Naito, C. Nozaki, S. Iwanaga, and M. Kuwano Angiostatin Generation by Cathepsin D Secreted by Human Prostate Carcinoma Cells J. Biol. Chem., December 1, 2000; 275(49): 38912 - 38920. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |